<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>53</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>36(8)</volume><submitter>Horisawa S</submitter><funding>Focused Ultrasound Foundation</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The efficacy of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for the treatment of focal hand dystonia (FHD) is not well known.&lt;h4>Objective&lt;/h4>We aimed to prospectively investigate the efficacy of MRgFUS thalamotomy for the treatment of FHD.&lt;h4>Methods&lt;/h4>We performed MRgFUS thalamotomy of the ventro-oral (Vo) nucleus in 10 patients with FHD. We evaluated the scores of the Writer's Cramp Rating Scale (WCRS, 0-30; higher scores indicating greater severity), Tubiana Musician's Dystonia Scale (TMDS, 0-5; lower scores indicating greater severity), and Arm Dystonia Disability Scale (ADDS, 0%-100%; lower scores indicating greater disability) at baseline and 3 and 12 months post-treatment.&lt;h4>Results&lt;/h4>WCRS, TMDS, and ADDS scores significantly improved from 6.3 ± 2.7, 1.4 ± 0.5, and 58.7% ± 14.3% at baseline to 1.6 ± 3.1 (P = 0.011), 5.0 ± 0 (P = 0.0001), and 81.6% ± 22.9% (P = 0.0229) at 12 months, respectively. There was one prolonged case of dysarthria at 12 months.&lt;h4>Conclusion&lt;/h4>We show that MRgFUS Vo-thalamotomy significantly improved FHD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</pubmed_abstract><journal>Movement disorders : official journal of the Movement Disorder Society</journal><pagination>1955-1959</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8453941</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Focal Hand Dystonia: A Pilot Study.</pubmed_title><pmcid>PMC8453941</pmcid><pubmed_authors>Iijima M</pubmed_authors><pubmed_authors>Konishi Y</pubmed_authors><pubmed_authors>Taira T</pubmed_authors><pubmed_authors>Kawamata T</pubmed_authors><pubmed_authors>Fukui A</pubmed_authors><pubmed_authors>Yamaguchi T</pubmed_authors><pubmed_authors>Hori H</pubmed_authors><pubmed_authors>Horisawa S</pubmed_authors><pubmed_authors>Abe K</pubmed_authors><pubmed_authors>Sumi M</pubmed_authors><pubmed_authors>Hodotsuka K</pubmed_authors><view_count>53</view_count></additional><is_claimable>false</is_claimable><name>Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Focal Hand Dystonia: A Pilot Study.</name><description>&lt;h4>Background&lt;/h4>The efficacy of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for the treatment of focal hand dystonia (FHD) is not well known.&lt;h4>Objective&lt;/h4>We aimed to prospectively investigate the efficacy of MRgFUS thalamotomy for the treatment of FHD.&lt;h4>Methods&lt;/h4>We performed MRgFUS thalamotomy of the ventro-oral (Vo) nucleus in 10 patients with FHD. We evaluated the scores of the Writer's Cramp Rating Scale (WCRS, 0-30; higher scores indicating greater severity), Tubiana Musician's Dystonia Scale (TMDS, 0-5; lower scores indicating greater severity), and Arm Dystonia Disability Scale (ADDS, 0%-100%; lower scores indicating greater disability) at baseline and 3 and 12 months post-treatment.&lt;h4>Results&lt;/h4>WCRS, TMDS, and ADDS scores significantly improved from 6.3 ± 2.7, 1.4 ± 0.5, and 58.7% ± 14.3% at baseline to 1.6 ± 3.1 (P = 0.011), 5.0 ± 0 (P = 0.0001), and 81.6% ± 22.9% (P = 0.0229) at 12 months, respectively. There was one prolonged case of dysarthria at 12 months.&lt;h4>Conclusion&lt;/h4>We show that MRgFUS Vo-thalamotomy significantly improved FHD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2024-11-19T14:57:48.826Z</modification><creation>2022-02-11T11:21:50.871Z</creation></dates><accession>S-EPMC8453941</accession><cross_references><pubmed>34050695</pubmed><doi>10.1002/mds.28613</doi></cross_references></HashMap>